CN Stock MarketDetailed Quotes

301201 Chengda Pharmaceuticals

Watchlist
  • 21.08
  • +0.21+1.01%
Market Closed Dec 27 15:00 CST
3.26BMarket Cap46.43P/E (TTM)

Chengda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
-5.84%332.33M
-3.45%214.68M
2.92%134.36M
9.84%456.28M
15.79%352.95M
2.21%222.34M
28.18%130.56M
9.68%415.41M
8.47%304.83M
8.15%217.54M
Refunds of taxes and levies
-65.80%285.77K
-65.80%285.77K
----
----
--835.61K
--835.61K
----
----
----
----
Cash received relating to other operating activities
-11.90%17.88M
20.71%12.46M
138.60%8.25M
-0.80%26.35M
-38.75%20.29M
-59.07%10.32M
-65.13%3.46M
132.12%26.56M
422.93%33.13M
398.45%25.22M
Cash inflows from operating activities
-6.31%350.49M
-2.60%227.42M
6.42%142.62M
9.20%482.63M
10.69%374.08M
-3.81%233.49M
19.90%134.01M
13.28%441.97M
17.60%337.96M
17.72%242.75M
Goods services cash paid
43.70%180.79M
39.24%108.74M
90.58%62.36M
-35.62%149.75M
-36.60%125.81M
-38.39%78.1M
-50.45%32.72M
32.98%232.62M
84.64%198.43M
80.49%126.77M
Staff behalf paid
13.54%61.63M
9.68%39.86M
5.32%20.51M
1.90%72.23M
-2.69%54.28M
11.54%36.34M
12.88%19.48M
14.67%70.89M
30.53%55.78M
22.48%32.59M
All taxes paid
42.24%14.22M
29.22%12.26M
72.26%8.88M
-52.21%13.93M
-49.94%10M
-9.36%9.49M
43.15%5.16M
30.33%29.14M
-3.62%19.97M
-33.33%10.47M
Cash paid relating to other operating activities
-4.36%35.93M
-6.71%19.84M
50.61%12.77M
-11.37%54.65M
-26.10%37.56M
-43.13%21.26M
-47.40%8.48M
28.65%61.66M
74.77%50.83M
100.22%37.39M
Cash outflows from operating activities
28.52%292.57M
24.46%180.7M
58.77%104.53M
-26.31%290.56M
-29.96%227.65M
-29.93%145.19M
-36.09%65.84M
28.42%394.31M
62.50%325.01M
57.91%207.21M
Net cash flows from operating activities
-60.44%57.92M
-47.10%46.71M
-44.14%38.08M
302.96%192.07M
1,030.26%146.43M
148.43%88.3M
679.23%68.18M
-42.67%47.67M
-85.17%12.96M
-52.60%35.54M
Investing cash flow
Cash received from disposal of investments
25.20%972.16M
-92.01%62.03M
----
15.21%1.28B
676.50%776.5M
870.63%776.5M
1,453.00%776.5M
--1.11B
--100M
--80M
Cash received from returns on investments
-20.15%23.82M
11.46%18.83M
14.78%9.34M
6.61%41.82M
214.63%29.83M
224.83%16.9M
873.80%8.13M
--39.23M
--9.48M
--5.2M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
530.01%2.27M
294.95%1.34M
-78.02%51.97K
18.68%343.46K
21.25%360.16K
27.09%339.37K
-11.44%236.48K
138.91%289.42K
175.38%297.04K
147.57%267.04K
Cash inflows from investing activities
23.75%998.25M
-89.64%82.2M
-98.80%9.39M
14.92%1.32B
634.84%806.69M
828.69%793.74M
1,435.88%784.87M
947,422.66%1.15B
101,673.72%109.78M
79,137.47%85.47M
Cash paid to acquire fixed assets intangible assets and other long-term assets
57.69%185.23M
78.99%130.07M
26.67%56.02M
9.23%224.67M
-3.73%117.46M
-8.54%72.67M
-0.77%44.22M
48.30%205.69M
4.82%122.02M
35.70%79.45M
Cash paid to acquire investments
--1.67B
--367.15M
--100.65M
-74.10%500M
----
----
----
--1.93B
--1.09B
--1.07B
Cash paid relating to other investing activities
----
----
----
----
----
----
--764.7K
----
----
----
Cash outflows from investing activities
1,481.23%1.86B
584.25%497.22M
248.26%156.67M
-66.08%724.67M
-90.31%117.46M
-93.68%72.67M
-94.97%44.99M
1,440.31%2.14B
941.17%1.21B
1,863.20%1.15B
Net cash flows from investing activities
-224.65%-859.13M
-157.56%-415.01M
-119.91%-147.28M
160.12%594.39M
162.53%689.22M
167.77%721.07M
187.72%739.89M
-613.40%-988.64M
-847.75%-1.1B
-1,720.58%-1.06B
Financing cash flow
Cash received from capital contributions
--380K
----
----
----
----
----
----
--1.64B
--1.64B
--1.64B
Cash from borrowing
----
----
----
----
----
----
----
-98.71%1.02M
-97.81%1.02M
-96.61%1.02M
Cash inflows from financing activities
--380K
----
----
----
----
----
----
1,975.73%1.64B
3,437.04%1.64B
5,370.81%1.64B
Borrowing repayment
----
----
----
----
----
----
----
250.00%70M
600.00%70M
--70M
Dividend interest payment
4.47%29.1M
--12.36K
--10.06K
-33.75%29.01M
-36.38%27.85M
----
----
39.73%43.79M
42.34%43.78M
44.28%43.78M
Cash payments relating to other financing activities
--57.07M
--55.28M
--51.93M
----
----
----
----
----
--15.94M
--14.76M
Cash outflows from financing activities
209.37%86.17M
--55.29M
--51.94M
-74.51%29.01M
-78.53%27.85M
----
----
121.65%113.79M
218.26%129.73M
323.60%128.55M
Net cash flows from financing activities
-208.00%-85.79M
---55.29M
---51.94M
-101.90%-29.01M
-101.84%-27.85M
----
----
5,418.47%1.53B
26,693.55%1.51B
437,049.82%1.51B
Net cash flow
Exchange rate change effecting cash and cash equivalents
133.33%1.81M
404.71%1.66M
1,187.15%99.25K
-34.56%804.06K
-34.46%774.7K
-50.38%328.59K
91.69%-9.13K
268.16%1.23M
458.23%1.18M
256.88%662.2K
Net increase in cash and cash equivalents
-209.48%-885.19M
-152.11%-421.93M
-119.93%-161.04M
29.41%758.26M
90.97%808.58M
66.98%809.7M
11.81%808.05M
2,154.14%585.94M
1,892.96%423.41M
2,973.55%484.92M
Add:Begin period cash and cash equivalents
125.45%1.36B
125.45%1.36B
125.66%1.36B
3,168.44%604.43M
3,168.44%604.43M
3,168.44%604.43M
3,168.44%604.43M
-60.67%18.49M
-60.67%18.49M
-60.67%18.49M
End period cash equivalent
-66.21%477.5M
-33.47%940.76M
-14.84%1.2B
125.45%1.36B
219.75%1.41B
180.91%1.41B
90.58%1.41B
3,168.44%604.43M
1,788.28%441.9M
701.68%503.41M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhonghua Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash -5.84%332.33M-3.45%214.68M2.92%134.36M9.84%456.28M15.79%352.95M2.21%222.34M28.18%130.56M9.68%415.41M8.47%304.83M8.15%217.54M
Refunds of taxes and levies -65.80%285.77K-65.80%285.77K----------835.61K--835.61K----------------
Cash received relating to other operating activities -11.90%17.88M20.71%12.46M138.60%8.25M-0.80%26.35M-38.75%20.29M-59.07%10.32M-65.13%3.46M132.12%26.56M422.93%33.13M398.45%25.22M
Cash inflows from operating activities -6.31%350.49M-2.60%227.42M6.42%142.62M9.20%482.63M10.69%374.08M-3.81%233.49M19.90%134.01M13.28%441.97M17.60%337.96M17.72%242.75M
Goods services cash paid 43.70%180.79M39.24%108.74M90.58%62.36M-35.62%149.75M-36.60%125.81M-38.39%78.1M-50.45%32.72M32.98%232.62M84.64%198.43M80.49%126.77M
Staff behalf paid 13.54%61.63M9.68%39.86M5.32%20.51M1.90%72.23M-2.69%54.28M11.54%36.34M12.88%19.48M14.67%70.89M30.53%55.78M22.48%32.59M
All taxes paid 42.24%14.22M29.22%12.26M72.26%8.88M-52.21%13.93M-49.94%10M-9.36%9.49M43.15%5.16M30.33%29.14M-3.62%19.97M-33.33%10.47M
Cash paid relating to other operating activities -4.36%35.93M-6.71%19.84M50.61%12.77M-11.37%54.65M-26.10%37.56M-43.13%21.26M-47.40%8.48M28.65%61.66M74.77%50.83M100.22%37.39M
Cash outflows from operating activities 28.52%292.57M24.46%180.7M58.77%104.53M-26.31%290.56M-29.96%227.65M-29.93%145.19M-36.09%65.84M28.42%394.31M62.50%325.01M57.91%207.21M
Net cash flows from operating activities -60.44%57.92M-47.10%46.71M-44.14%38.08M302.96%192.07M1,030.26%146.43M148.43%88.3M679.23%68.18M-42.67%47.67M-85.17%12.96M-52.60%35.54M
Investing cash flow
Cash received from disposal of investments 25.20%972.16M-92.01%62.03M----15.21%1.28B676.50%776.5M870.63%776.5M1,453.00%776.5M--1.11B--100M--80M
Cash received from returns on investments -20.15%23.82M11.46%18.83M14.78%9.34M6.61%41.82M214.63%29.83M224.83%16.9M873.80%8.13M--39.23M--9.48M--5.2M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset 530.01%2.27M294.95%1.34M-78.02%51.97K18.68%343.46K21.25%360.16K27.09%339.37K-11.44%236.48K138.91%289.42K175.38%297.04K147.57%267.04K
Cash inflows from investing activities 23.75%998.25M-89.64%82.2M-98.80%9.39M14.92%1.32B634.84%806.69M828.69%793.74M1,435.88%784.87M947,422.66%1.15B101,673.72%109.78M79,137.47%85.47M
Cash paid to acquire fixed assets intangible assets and other long-term assets 57.69%185.23M78.99%130.07M26.67%56.02M9.23%224.67M-3.73%117.46M-8.54%72.67M-0.77%44.22M48.30%205.69M4.82%122.02M35.70%79.45M
Cash paid to acquire investments --1.67B--367.15M--100.65M-74.10%500M--------------1.93B--1.09B--1.07B
Cash paid relating to other investing activities --------------------------764.7K------------
Cash outflows from investing activities 1,481.23%1.86B584.25%497.22M248.26%156.67M-66.08%724.67M-90.31%117.46M-93.68%72.67M-94.97%44.99M1,440.31%2.14B941.17%1.21B1,863.20%1.15B
Net cash flows from investing activities -224.65%-859.13M-157.56%-415.01M-119.91%-147.28M160.12%594.39M162.53%689.22M167.77%721.07M187.72%739.89M-613.40%-988.64M-847.75%-1.1B-1,720.58%-1.06B
Financing cash flow
Cash received from capital contributions --380K--------------------------1.64B--1.64B--1.64B
Cash from borrowing -----------------------------98.71%1.02M-97.81%1.02M-96.61%1.02M
Cash inflows from financing activities --380K------------------------1,975.73%1.64B3,437.04%1.64B5,370.81%1.64B
Borrowing repayment ----------------------------250.00%70M600.00%70M--70M
Dividend interest payment 4.47%29.1M--12.36K--10.06K-33.75%29.01M-36.38%27.85M--------39.73%43.79M42.34%43.78M44.28%43.78M
Cash payments relating to other financing activities --57.07M--55.28M--51.93M----------------------15.94M--14.76M
Cash outflows from financing activities 209.37%86.17M--55.29M--51.94M-74.51%29.01M-78.53%27.85M--------121.65%113.79M218.26%129.73M323.60%128.55M
Net cash flows from financing activities -208.00%-85.79M---55.29M---51.94M-101.90%-29.01M-101.84%-27.85M--------5,418.47%1.53B26,693.55%1.51B437,049.82%1.51B
Net cash flow
Exchange rate change effecting cash and cash equivalents 133.33%1.81M404.71%1.66M1,187.15%99.25K-34.56%804.06K-34.46%774.7K-50.38%328.59K91.69%-9.13K268.16%1.23M458.23%1.18M256.88%662.2K
Net increase in cash and cash equivalents -209.48%-885.19M-152.11%-421.93M-119.93%-161.04M29.41%758.26M90.97%808.58M66.98%809.7M11.81%808.05M2,154.14%585.94M1,892.96%423.41M2,973.55%484.92M
Add:Begin period cash and cash equivalents 125.45%1.36B125.45%1.36B125.66%1.36B3,168.44%604.43M3,168.44%604.43M3,168.44%604.43M3,168.44%604.43M-60.67%18.49M-60.67%18.49M-60.67%18.49M
End period cash equivalent -66.21%477.5M-33.47%940.76M-14.84%1.2B125.45%1.36B219.75%1.41B180.91%1.41B90.58%1.41B3,168.44%604.43M1,788.28%441.9M701.68%503.41M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhonghua Certified Public Accountants (Special General Partnership)------Zhonghua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Innovative Drugs
Innovative Drugs
Intraday+0.47%